VYNDAMAX (Pfizer)
(https://vyndaqel.com) 📸 Data Snapshot: June 20, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Authority is generally strong due to references to the American College of Cardiology and American Heart Association. A minor gap exists with ‘Stan, a real patient,’ who lacks a digital footprint or Person schema, unlike ‘Jack Nicklaus,’ whose identity is globally verifiable. The Pfizer manufacturer identity is clearly established via JSON-LD schema.
There is almost no disconnect between marketing tone and clinical reality. The marketing claim of ‘Live longer’ is tempered with a specific footnote stating that while 71% were alive, the overall summary scores actually ‘had worse KCCQ overall summary scores at month 30 than at the start of the study.’ This level of transparency in performance claims is rare and reduces BS significantly.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
[
{
"@context": "http://schema.org/",
"@type": "MedicalWebPage",
"specialty": "https://schema.org/Cardiovascular",
"audience": "https://schema.org/Patient",
"url": "https://www.vyndamax.com/",
"headline": "VYNDAMAX® (tafamidis) Prescription Treatment for ATTR-CM | Safety Info",
"description": "VYNDAMAX® is used to treat wild-type & hereditary forms of transthyretin amyloid cardiomyopathy (ATTR-CM) in adults. Learn more about the risks and benefits.",
"image": {
"@type": "ImageObject",
"description": "VYNDAMAX (tafamidis) 61mg logo",
"url": "https://www.vyndamax.com/profiles/pfvyndamaxcom_profile/themes/custom/vyndamax/vyndamax-tafamidis-logo.svg"
},
"about": [
{
"@type": "Drug",
"name": "VYNDAMAX",
"nonProprietaryName": "tafamidis",
"image": {
"@type": "ImageObject",
"name": "VYNDAMAX® (tafamidis)",
"description": "VYNDAMAX (tafamidis) 61mg logo",
"contentUrl": "https://www.vyndamax.com/profiles/pfvyndamaxcom_profile/themes/custom/vyndamax/vyndamax-tafamidis-logo.svg"
},
"description": "VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.",
"prescribingInfo": "http://labeling.pfizer.com/ShowLabeling.aspx?id=11685",
"warning": "Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:\nhave liver problems.\nare pregnant or plan to become pregnant.\nare breastfeeding or plan to breastfeed.\nTell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.\nThere were no known side effects that happened during treatment with VYNDAMAX.",
"dosageForm": "Capsule",
"administrationRoute": [
"Swallow",
"oral"
],
"doseSchedule": {
"@type": "DoseSchedule",
"frequency": "VYNDAMAX offers convenient once-daily dosing. A single 61-mg, once-daily capsule. A pill taken by mouth .It is important to continue taking VYNDAMAX as prescribed by your doctor. VYNDAMAX capsules should be swallowed whole and never crushed or cut. If you miss a dose, take it as soon as you remember. If it is time for your next dose, skip the missed dose and take the next dose at your regularly scheduled time. Do not take 2 doses at the same time."
},
"offers": {
"@type": "Offer",
"price": "0",
"priceCurrency": "USD",
"url": "https://www.vyndamax.com/financial-assistance"
},
"mechanismOfAction": "VYNDAMAX helps hold the TTR protein together. This can reduce the buildup of dangerous amyloid deposits in the heart and slow down ATTR-CM. ATTR-CM happens when a protein called transthyretin (TTR) breaks down and turns into amyloid. Amyloid can build up in the heart making it harder for the heart to pump effectively. The TTR protein is mostly made in the liver and in smaller amounts in the outer lining of the brain and retina.",
"manufacturer": {
"@type": "Corporation",
"name": "Pfizer",
"logo": "https://www.pfizer.com/profiles/pfecpfizercomus_profile/themes/pfecpfizercomus/public/assets/images/logo-blue.svg"
}
}
]
}
]
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 6 | 0 |
| /jacks-journey/ | 0 | 0 |
| /financial-assistance/ | 0 | 0 |
| /about-vyndamax/ | 6 | 0 |
This page presents a snapshot of public data from VYNDAMAX (Pfizer), captured on June 20, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to VYNDAMAX (Pfizer): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://vyndaqel.com to view the most current version of its content and see directly what this company is about and what it offers.